← All stocks

ImmunityBio, Inc.

IBRX Scheduled selling only

CIK 0001326110 #1027 in the set updated 18 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$8.39M

$4.14M on a plan · $4.24M straight out of an exercise

Sold at will

$0.00

0 of 14 sales

Net

−$8.39M

$0.00 against sales at will

By person

7 insiders · 15 transactions

6.4×

Richard Adcock holds 6.4 times base salary in stock. $5.33M of shares against $831.67K in salary for 2025.

Salary from the company's own proxy. The shares are what Richard Adcock last reported holding, valued at $9.50, the price Common Stock was last bought or sold at on the open market here, on 2 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Simon Barry J.

Director

—

$4.14M (7) scheduled

−$4.14M

2,802,788

0.2645%

$26.64M

−10.3%

Selecky Christobel

Director

—

$3.00M (6) scheduled

−$3.00M

0.0000%

$0.00

—

Cohen Cheryl

Director

—

$1.25M (1) scheduled

−$1.25M

125,386

0.0118%

$1.19M

−37.5%

SOON-SHIONG PATRICK

See remarks

—

280,776,784

26.49%

$2.67B

+76.9%

Adcock Richard

CEO & President

—

560,344

0.0529%

$5.33M

+130.5%

Sachs David C.

Chief Financial Officer

—

300,143

0.0283%

$2.85M

+61.5%

LAUER REGAN J

Chief Accounting Officer

—

115,875

0.0109%

$1.10M

+22.8%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Cohen Cheryl

2 Jul 2026

Director

Sold after exercise

131,210

$9.50

$1.25M

Selecky Christobel

1 Jul 2026

Director

Sold after exercise

159,478

$9.02

$1.44M

Selecky Christobel

30 Jun 2026

Director

Sold after exercise

1,000

$9.00

$9.00K

Selecky Christobel

29 Jun 2026

Director

Sold after exercise

95,722

$9.01

$862.22K

Selecky Christobel

23 Feb 2026

Director

Sold after exercise

25,000

$10.00

$250.00K

Selecky Christobel

20 Jan 2026

Director

Sold after exercise

25,000

$7.51

$187.65K

Selecky Christobel

16 Jan 2026

Director

Sold after exercise

50,000

$5.00

$250.00K

Show all 15 transactions →

What was left out

Form 4 filings counted 28

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 3

Sales on a Rule 10b5-1 plan 7

Sales straight out of an exercise 7

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 6,546,907

History held since 9 Sep 2016